Changes in the hair growth cycle in women with non-scarring alopecia

    October 2018 in “Vestnik dermatologii i venerologii
    А. А. Кубанов, А. А. Кубанов, Yu. A. Gallyamova, Ю. А. Галлямова, O. A. Korableva, O. A. Korableva
    Image of study
    TLDR Certain growth factors affect hair loss in women and could be targeted for treatment.
    In 2018, a study involving 60 women with non-scarring alopecia, specifically androgenetic alopecia and telogen hair loss, was conducted to examine the role of growth factors VEGF, KGF, EGF, and TGF-01 in alopecia development. The study discovered that the expression of these growth factors differed in women with alopecia compared to healthy individuals, with VEGF having the most significant impact on androgenetic alopecia development. VEGF also affected telogen hair loss more than EGF. The results suggested potential use of VEGF and KGF growth factors, and TGF-01 inhibitors, as treatment for patients with androgenetic alopecia and telogen hair loss.
    View this study on vestnikdv.ru →

    Cited in this study

    Related

      Towards a molecular understanding of hair loss and its treatment

      research Towards a molecular understanding of hair loss and its treatment

      236 citations ,   July 2001 in “Trends in Molecular Medicine”
      Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.
      Treatment of Hair Loss

      research Treatment of Hair Loss

      370 citations ,   September 1999 in “The New England Journal of Medicine”
      Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.